The COVID-19 pandemic has upended the clinical trial landscape in ways large and small, agreed experts on the final day of the ACRP 2021 virtual conference’s January track (January 14). On the positive side, it showed the clinical trial workforce in a favorable new light—one in which professionals rose to the occasion, in part […]
Calling it a “timely conversation,” Eric Pittman, director of the Bioresearch Monitoring Division at the U.S. Food and Drug Administration (FDA), told attendees of the second day of the ACRP 2021 virtual conference’s opening block of sessions yesterday (January 13) that the agency is enthusiastic about how decentralized clinical trials (DCTs)—in one form or […]
Fresh from a huge and successful project putting together a COVID-19 biorepository, leaders at the Medical University of South Carolina (MUSC) shared some best practices with attendees of the first block of sessions for the ACRP 2021 virtual conference yesterday (January 12). “Centralize communications and information as much as possible,” said Amanda Cameron, manager […]
While there is currently no cure for fatty liver disease (FLD) or nonalcoholic steatohepatitis (NASH), a condition to which FLD can lead, the pharmaceutical industry is turning to clinical research to understand the causes, development, and treatment of these diseases. To better understand attitudes toward clinical research and why patients might consider a clinical trial […]
